Search results
Impact of Hypopnoea Classifications in Heart Failure
Author(s):
Sébastien Baillieul
,
Renaud Tamisier
,
Jean-Louis Pépin
Added:
6 months ago
Review Article
Home Sleep Apnoea Testing in Heart Failure
Author(s):
Rebecca Steinberg
,
Andrew R Spector
,
Todd McVeigh
,
et al
Added:
6 months ago
Review Article
Author(s):
Marat Fudim
Added:
1 year ago
In this short interview, Dr Marat Fudim offers a preview of his upcoming manuscript, set to appear in the Sleep Disordered Breathing in Heart Failure special focus collection in Cardiac Failure Review. He discusses the evolving role of home sleep testing in diagnosing sleep apnea in patients with heart failure, addressing key considerations in clinical workflows and patient selection.Watch now to…
View more
Phrenic Nerve Stimulation for Central Sleep Apnoea
Author(s):
Jonathan Na
,
Miguel Valderrábano
,
Paul Schurmann
Added:
5 months ago
Review Article
Author(s):
Tarek Bekfani
,
Joseph D Abraham
,
William T Abraham
Added:
9 months ago
Author(s):
Heba Wassif
Added:
6 months ago
Navigate the diagnostic and therapeutic landscape of autoimmune disorders and cardiomyopathy with Dr Heba WassifThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical intersection between immune-mediated inflammatory disorders and cardiovascular disease.Dr Wassif examines the spectrum and epidemiology of immune-mediated inflammatory disorders, emphasizing their…
View more
Author(s):
Milton Packer
Added:
6 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core…
View more
Author(s):
Barry Borlaug
Added:
8 months ago
HFSA 25 - Sex-specific outcomes of tirzepatide in obesity-related HFpEF showed that at baseline, women with HFpEF had more severe heart failure symptoms.Dr Barry Borlaug (Mayo Clinic, US) joins us to discuss a prespecified secondary analysis from the SUMMIT trial, examining sex-specific effects of tirzepatide in patients with heart failure with preserved ejection fraction and obesity.The SUMMIT…
View more
Undiagnosed Sleep Apnoea Linked to Adverse Myocardial Remodelling in Hypertrophic Cardiomyopathy
Added:
8 months ago
Source:
Radcliffe Cardiology
News
PAP Therapies for HF: What Do the Trials Tell Us?
Author(s):
Jan Pec
,
Michael Arzt
Added:
6 months ago
Review Article
